Shree Ram Proteins
Close ·
- P/E
- Not meaningful: loss-making over the last twelve months
Key Fundamentals
MicrocapFMCG ProductsFMCGPrice-based figures at the close · EPS basis: Standalone · TTM
- ROCE
- −6.20%
- Debt to Equity
- 2.47
- EPS (TTM)
- −₹0.35
- Book Value
- ₹0.87
- Market Cap
- —
- P/E (TTM)
- Not meaningful: loss-making over the last twelve months
- P/B
- 0.39
- ROE
- −20.60%
- Dividend Yield
- 0.00%
- EBITDA
- −₹16.90 Cr
- 52W High
- ₹0.72
- 52W Low
- ₹0.32
Peer Comparison
Fast Moving Consumer Goods › Agricultural Food & other Products › Edible Oil
| ₹890.00 | 61.21 | ₹1,15,652 Cr | 24.44 | 0.46% | 42.80% | 47.00% | ₹14,277 Cr | ₹1,952 Cr | |
| ₹383.90 | 21.19 | ₹41,267 Cr | 3.19 | 0.21% | 16.00% | 12.10% | ₹42,754 Cr | ₹1,971 Cr | |
| ₹163.85 | 18.41 | ₹21,447 Cr | 1.96 | 0.61% | 10.70% | 18.30% | ₹77,720 Cr | ₹1,158 Cr | |
| ₹223.06 | 15.65 | ₹6,549 Cr | 3.88 | 0.00% | 30.00% | 36.70% | ₹24,435 Cr | ₹421 Cr | |
| ₹1,163.25 | 10.11 | ₹3,256 Cr | 1.55 | 0.00% | 10.80% | 12.30% | ₹2,310 Cr | ₹323 Cr | |
| ₹728.90 | 108.79 | ₹1,584 Cr | 13.68 | 0.14% | 33.70% | 19.80% | ₹597 Cr | ₹15 Cr | |
| ₹187.94 | 13.18 | ₹485 Cr | 1.22 | 0.00% | 8.86% | 13.60% | ₹1,945 Cr | ₹36 Cr | |
| ₹0.34 | — | ₹15 Cr | 0.39 | 0.00% | −20.60% | −6.20% | ₹0 Cr | −₹15 Cr | |
| Median 8 companies | ₹303.48 | 18.41 | ₹4,902 Cr | 2.58 | 0.07% | 13.40% | 15.95% | ₹8,294 Cr | ₹372 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Key Insights
Strengths
1- Stock is trading at 0.95 times its book value
Weaknesses
5- Company has low interest coverage ratio.
- Promoter holding is low: 4.08%
- Company has a low return on equity of -32.6% over last 3 years.
- Company might be capitalizing the interest cost
- Promoter holding has decreased over last 3 years: -13.0%
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 2 | 5 |
| Oscillators | Strong Bullish | 2 | 2 | 5 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Strong Bullish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 15.26
- Bullish
- MACD (12,26,9)
- −0.05
- Bearish
- SMA (50)
- 0.51
- Bearish
- SMA (200)
- 0.65
- Bearish
As of , the latest day with price data, so these readings are not current.
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | −100.00% |
|---|---|
| 5Y | −100.00% |
| 3Y | −100.00% |
| 1Y | Zero base |
| TTM | Zero base |
Net profit
| 10Y | Turned to loss |
|---|---|
| 5Y | Turned to loss |
| 3Y | Turned to loss |
| 1Y | Loss narrowed by ₹11 Cr |
| TTM | Loss narrowed by ₹7.75 Cr |
Operating cash flow
| 10Y | 0.00% |
|---|---|
| 5Y | 0.00% |
| 3Y | Turned positive |
| 1Y | −50.00% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | No sales |
|---|---|
| 5Y | No sales |
| 3Y | No sales |
| 1Y | No sales |
| TTM | No sales |
Revenue by year
| Mar 2017 | ₹158 Cr |
|---|---|
| Mar 2018 | ₹195 Cr |
| Mar 2019 | ₹158 Cr |
| Mar 2020 | ₹156 Cr |
| Mar 2021 | ₹153 Cr |
| Mar 2022 | ₹288 Cr |
| Mar 2023 | ₹163 Cr |
| Mar 2024 | ₹15.00 Cr |
| Mar 2025 | ₹0.00 Cr |
| Mar 2026 | ₹0.00 Cr |
Net profit by year
| Mar 2017 | ₹1.00 Cr |
|---|---|
| Mar 2018 | ₹2.00 Cr |
| Mar 2019 | ₹3.00 Cr |
| Mar 2020 | ₹3.00 Cr |
| Mar 2021 | ₹1.00 Cr |
| Mar 2022 | ₹6.00 Cr |
| Mar 2023 | ₹4.00 Cr |
| Mar 2024 | −₹10.00 Cr |
| Mar 2025 | −₹21.00 Cr |
| Mar 2026 | −₹10.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.11 | 5.66 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 7.66 | 7.48 | 4.55 | 3.29 | 0.25 | 0.3 | 0.18 | 0.18 | 1.69 | 0.11 | 0.18 | 2.49 | 0.46 |
| Operating Profit | 1.45 | −1.82 | −4.55 | −3.29 | −0.25 | −0.3 | −0.18 | −0.18 | −1.69 | −0.11 | −0.18 | −2.49 | −0.46 |
| OPM % | 15.92% | −32.16% | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 0.1 | 0.23 | 0 | 0.01 | 0 | −7.89 | −4.15 | −3.99 | 0.01 | −4.72 | 0 | 0.01 | 1.4 |
| Interest | 1.06 | 0.36 | 0.01 | 0 | 0 | 3.38 | 0.02 | 0 | 0 | 0.01 | 0 | 0 | 7.21 |
| Depreciation | 0.21 | 0.21 | 0.21 | 0.21 | 0.17 | 0.03 | 0.31 | 0.17 | 0.14 | 0.14 | 0.14 | 0.14 | 0.09 |
| PBT | 0.29 | −2.15 | −4.76 | −3.49 | −0.42 | −11.6 | −4.66 | −4.34 | −1.82 | −4.98 | −0.32 | −2.62 | −6.36 |
| Tax % | 28.57% | −11.57% | −3.77% | −4.87% | 19.05% | 0% | 0% | −0.46% | −0.55% | −0.2% | −3.12% | 14.5% | 0% |
| Net Profit | 0.21 | −1.89 | −4.58 | −3.32 | −0.5 | −11.6 | −4.66 | −4.32 | −1.82 | −4.97 | −0.32 | −3 | −6.36 |
| EPS (₹) | 0 | −0.04 | −0.11 | −0.08 | −0.01 | −0.27 | −0.11 | −0.1 | −0.04 | −0.12 | −0.01 | −0.07 | −0.15 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 174 | 183 | 158 | 195 | 158 | 156 | 153 | 288 | 163 | 15 | 0 | 0 | 0 |
| Expenses | 167 | 176 | 151 | 188 | 149 | 148 | 147 | 275 | 152 | 23 | 19 | 3 | 3 |
| Operating Profit | 8 | 7 | 6 | 8 | 9 | 8 | 6 | 13 | 11 | −8 | −19 | −3 | −3 |
| OPM % | 4.5% | 3.7% | 4% | 4% | 6% | 5% | 3.8% | 4.5% | 6% | −54% | — | — | — |
| Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 3 | −6 | −3 |
| Interest | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 2 | 3 | 0 | 7 |
| Depreciation | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| PBT | 1 | 1 | 1 | 3 | 4 | 4 | 1 | 8 | 5 | −10 | −21 | −10 | −14 |
| Tax % | −14% | 33% | 30% | 37% | 25% | 26% | 24% | 26% | 27% | −5% | 0% | 4% | — |
| Net Profit | 1 | 1 | 1 | 2 | 3 | 3 | 1 | 6 | 4 | −10 | −21 | −10 | −15 |
| EPS (₹) | 0.11 | 0.02 | 0.02 | 0.04 | 0.08 | 0.06 | 0.02 | 0.14 | 0.09 | −0.22 | −0.49 | −0.24 | −0.35 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 15 | 15 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
| Reserves | 3 | 4 | 4 | 18 | 21 | 24 | 25 | 31 | 35 | 25 | 4 | −6 |
| Borrowings | 55 | 50 | 47 | 47 | 42 | 40 | 44 | 43 | 37 | 37 | 38 | 37 |
| Other Liabilities | 39 | 15 | 21 | 26 | 12 | 16 | 10 | 21 | 13 | 15 | 15 | 17 |
| Total Liabilities | 104 | 84 | 88 | 113 | 97 | 101 | 100 | 116 | 106 | 98 | 79 | 69 |
| Fixed Assets | 15 | 13 | 11 | 11 | 10 | 8 | 7 | 7 | 7 | 6 | 5 | 4 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 89 | 71 | 76 | 102 | 87 | 92 | 93 | 109 | 99 | 93 | 74 | 65 |
| Total Assets | 104 | 84 | 88 | 113 | 97 | 101 | 100 | 116 | 106 | 98 | 79 | 69 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 9 | 1 | 6 | −14 | 8 | 5 | 1 | 36 | −20 | 1 | 2 | 1 |
| Investing | 0 | 0 | 0 | −1 | 0 | 0 | 0 | 0 | −1 | 1 | 0 | 0 |
| Financing | −11 | −1 | −7 | 15 | −8 | −6 | −1 | −6 | −10 | −1 | −2 | −1 |
| Net Cash Flow | −1 | 0 | 0 | 0 | 0 | 0 | 0 | 30 | −31 | 0 | 0 | 0 |
| Free Cash Flow | 9 | 1 | 6 | −14 | 8 | 5 | 1 | 36 | −20 | 1 | 2 | 1 |
| CFO/EBITDA | 119 | 23 | 108 | −171 | 114 | 77 | 32 | 287 | −194 | −7 | −11 | −32 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 122 | 74 | 88 | 98 | 86 | 120 | 104 | 10 | 62 | 586 | — | — |
| Inventory Days | 65 | 66 | 90 | 95 | 121 | 99 | 121 | 85 | 96 | 678 | — | — |
| Days Payable | 63 | 28 | 49 | 46 | 27 | 36 | 23 | 25 | 20 | 184 | — | — |
| Cash Conversion Cycle | 123 | 112 | 128 | 147 | 180 | 183 | 202 | 70 | 138 | 1,080 | — | — |
| Working Capital Days | 104 | 109 | 53 | 85 | 100 | 108 | 119 | 31 | 127 | 1,249 | — | — |
| ROCE % | — | 8% | 7% | 8% | 9% | 8% | 6% | 14% | 10% | −10% | −24% | −6% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Shree Ram Proteins insights
55 extracted metrics across FY15–FY27.
Documents
- 5 Feb 2026
- 28 Jan 2026
- 13 Nov 2025
- 13 Nov 2025
- 4 Nov 2025
- 5 Aug 2026
- 5 Aug 2026
- 24 Apr 2026
- 8 Jul 2025
- 14 Feb 2025
- Certificate under sebi (depositories and participa 14 Oct 2026
Frequently Asked Questions about Shree Ram Proteins
What does Shree Ram Proteins Ltd do?
Where is Shree Ram Proteins Ltd (SRPL) listed?
Which sector does Shree Ram Proteins Ltd belong to?
What is the 52-week high and low of Shree Ram Proteins Ltd?
What is the Return on Equity (ROE) of Shree Ram Proteins Ltd?
Company Information
Incorporated in 2008, Shree Ram Proteins Ltd is in the business of edible oil and solvent extraction from all types of agro
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SRPL.md for Shree Ram Proteins Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.